SCHEMBL14348285

SCHEMBL14348285

CCNC(=O)[C@H](CC1CC1)[C@H](CCC1CCCC1)C(N)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.38
CPB2 Q96IY4 7/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
REN P00797 1/20 0.35
CTSD P07339 2/20 0.35
METAP1 P53582 1/20 0.35
ABL1 P00519 1/20 0.35
FGFR3 P22607 1/20 0.35
DDR1 Q08345 1/20 0.35
MAPK11 Q15759 1/20 0.35
MAPK14 Q16539 1/20 0.35
DDR2 Q16832 1/20 0.35
MAP3K20 Q9NYL2 1/20 0.35
MAP3K4 Q9Y6R4 1/20 0.35
TSHR P16473 1/20 0.34
BCHE P06276 1/20 0.34
NMT2 O60551 1/20 0.33
NMT1 P30419 1/20 0.33
CTSS P25774 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14348134 1.00 METAP2 (0.38) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL13359678 1.00 METAP2 (0.38) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL8427666 1.00 METAP2 (0.38) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL13359716 0.99 METAP2 (0.38) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL14348289 0.99 METAP2 (0.38) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL8426474 0.97 METAP2 (0.38) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL14374472 0.97 METAP2 (0.38) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL14348288 0.97 METAP2 (0.35) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL8426458 0.97 METAP2 (0.35) METAP2CPB2ALDH1A1KMT2AREN
SCHEMBL14348564 0.96 ACACB (0.33) METAP2CPB2ALDH1A1KMT2AREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7304056-B2 Succinoylamino lactams as inhibitors of Aβ protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-12-04 US disclosed
US-7304049-B2 Succinoylaminobenzodiazepines as inhibitors of Aβ protein production BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-12-04 US disclosed